Application of hyaluronic acid in preparing medicines for preventing or treating ferroptosis-related diseases
US12233085B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Sep 4, 2023 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | Sep 4, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An application of hyaluronic acid in preparing medicines for preventing or treating ferroptosis-related diseases is provided, and an application of hyaluronic acid or salts of hyaluronic acid or derivatives of hyaluronic acid in preparing medicines for inhibiting ferroptosis is also provided. According to the present application, the anti-ferroptosis function of hyaluronic acid is disclosed. The hyaluronic acid is the first natural extracellular matrix material with anti-ferroptosis function found at present. The hyaluronic acid is one of the components of natural extracellular matrix and exists in large quantities in human body and is also a widely used material in clinic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.